$ACHN Company News Achillion Pharma's stock jumps 60%

New Post Public Reply Private Reply Replies (0) Message Board

Dec 26, 2014 at 11:40 AM

$ACHN Company News

Achillion Pharma's stock jumps 60% premarket after positive drug trial results 7:30 a.m. Dec. 22, 2014 - Tomi Kilgore
4 stocks to watch 3:41 p.m. Dec. 3, 2014 - The Trading Deck
6 stocks to watch 1:35 p.m. Oct. 29, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
6 stocks to watch 2:36 p.m. Oct. 9, 2014 - The Trading Deck
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 12:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 10:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 3:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 8:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 9:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch

February 2015 Options Now Available For Achillion Pharmaceuticals 12:30 p.m. Dec. 24, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Dec. 24, 2014 - Zacks.com
Morning Market Movers 8:42 a.m. Dec. 24, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:09 a.m. Dec. 24, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog 5:00 p.m. Dec. 23, 2014 - Zacks.com
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Mid-Day Losers From December 23: Achillion Pharmaceuticals, Doral Financial, Keurig Green Mountain And More 12:44 p.m. Dec. 23, 2014 - benzinga.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
Worst Performing Industries For December 23, 2014 10:25 a.m. Dec. 23, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations 9:40 a.m. Dec. 23, 2014 - benzinga.com
Morning Market Losers 9:03 a.m. Dec. 23, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Rises: Stock Adds 9% in Session - Tale of the Tape 8:44 a.m. Dec. 23, 2014 - Zacks.com
Analysts' Actions: Achillion, Avon, Kimberly-Clark, Salesforce.com 8:24 a.m. Dec. 23, 2014 - TheStreet.com
Tuesday's #PreMarket Movers: NQ Mobile, Cytokinetics, Walgreen And More 8:23 a.m. Dec. 23, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 8:21 a.m. Dec. 23, 2014 - Zacks.com
Benzinga's Top Downgrades 8:00 a.m. Dec. 23, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Baker Hughes, CryoLife, Halliburton, Nabors, Red Hat, Sonus and More 8:00 a.m. Dec. 23, 2014 - 247WallSt.com
Baird Downgrades Achillion Pharmaceuticals To Neutral 6:54 a.m. Dec. 23, 2014 - benzinga.com

Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
Traders Look to Upside: Research Reports on Achillion, Civitas, Twitter, Petrobras, and Zynga 8:50 a.m. Dec. 23, 2014 - PR Newswire - PRF
Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics 9:10 a.m. Dec. 22, 2014 - PR Newswire - PRF
Achillion Shows Potential for "Best-in-Disease" HCV Regimen - 100% SVR4 Following a Dual 6-Week ACH-3102-Based Regimen and Separately a 4.8 Log10 Reduction With ACH-3422 6:30 a.m. Dec. 22, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Linn Energy, Sears Holdings, Baidu and Qualcomm Released By InvestorsObserver 9:31 a.m. Dec. 1, 2014 - PR Newswire - PRF
Achillion to Present at Two Upcoming Investor Conferences 6:05 a.m. Nov. 25, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. Nov. 11, 2014 - PR Newswire - PRF
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD) 9:02 a.m. Nov. 8, 2014 - GlobeNewswire
Achillion Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform at the 56th Annual Meeting of the American Society of Hematology 9:02 a.m. Nov. 6, 2014 - GlobeNewswire
Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Achillion Reports Third Quarter and Nine Month 2014 Financial Results 6:31 a.m. Nov. 4, 2014 - GlobeNewswire
Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Oct. 27, 2014 - PR Newswire - PRF
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:24 a.m. Oct. 8, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 8:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 8:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 8:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 7:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 8:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 7:55 a.m. Sept. 2, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lear Corporation Talks Future at Morgan Stanley Conference

Why the Chatter at Laguna Conference Matters Alright folks, here's the scoop that the suits over at Lear are gearing up for: a fireside chat at the Morgan Stanley 14th Annual Laguna Conference. At first glance, you might shrug and say, "Big deal." But what's a conference worth if not to attract a bit of investor buzz, right? With Ray Scott, the President and CEO, and...

Eosera Defies Odds with Texas-Made Ear Care Dominance

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

ePlus Wins Big: First Ambassador Partner for Everpure

ePlus Breaks Ground with Everpure There's a new chapter unfolding in the tech sector, and ePlus has carved its name on the marquee. Achieving the exclusive Ambassador Partner Status with Everpure, ePlus becomes the first in North America to hit this high note. In the crowded room of tech partnerships, this isn't just a pat on the back—it's a gold star that screams...

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Ecobat's Strategic Shift: Exiting Lithium for Lead

You ever get that sense of déjà vu when another company decides to jump ship from a supposedly hot market? Well, that's where Ecobat's at, folks. This global player in battery recycling just waved goodbye to its lithium recycling biz, closing the deal on its Arizona operations. Previously, they ditched similar holdings in the UK and Germany. Now, they're all-in on their...

AEC Firms Revamp Strategies Amid Talent Tug-of-War

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Scrutinizing GPRO and VCTR Deals for Shareholders

GoPro and Victory Capital: Fair Play or Foul? Ah, mergers and acquisitions—the high-stakes poker game of the corporate world. These days, GoPro (NASDAQ:GPRO) and Victory Capital (NASDAQ:VCTR) find themselves right in the thick of things. Now, I’ve seen enough corporate chess games to know when to raise an eyebrow, and folks, that's exactly what's happening here. The...

Opus Group Revamps Turkish Vehicle Inspection System

Leveraging Expertise in Vehicle Inspection Opus Group is gearing up to revolutionize the vehicle inspection landscape in Türkiye. With a staggering 34.5 million vehicles on the roads, and an annual inspection quota hitting 16 million, the market is ripe for innovation. The U.S.-based Opus Group, a giant in the realm of vehicle inspection programs with about 30 million...

PMI Foods Fuels Hunger Action Month with New Partnership

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Shell Seals ARC Acquisition, $16.5B Bet on Future

Shell’s Strategic Play: Snagging ARC When it comes to Shell, they don't dawdle with peanuts. Snagging ARC Resources Ltd., a Canadian energy firm rooted squarely in British Columbia and Alberta, speaks volumes about their appetite for growth. They’re shelling out approximately US$16.5 billion to pull this deal off the ground. This isn't just some casual sector play; it...